H.R. 2820 — Reported in House

IB Union Calendar No. 183 114th CONGRESS 1st Session H. R. 2820 [Report No. 114–242] IN THE HOUSE OF REPRESENTATIVES June 18, 2015 Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Jolly, and Mr. Fattah) introduced the following bill; which was referred to the Committee on Energy and Commerce September 8, 2015 Additional sponsors: Mr. Grijalva, Mr. Huelskamp, Mr. Bilirakis, Mr. Murphy of Pennsylvania, Mrs. Ellmers of North Carolina, Mr. Roskam, Mr. Harris, Mr. DeFazio, Mr. Aderholt, Mr. Nolan, Mr. Newhouse, Mr. Ross, Mr. Lance, Mr. Barletta, Mr. Burgess, Ms. Eshoo, Mr. Loebsack, Mr. Hudson, and Ms. Pingree September 8, 2015 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed A BILL To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. 1. Short title This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2015. 2. Amendments to the Stem Cell Therapeutic and Research Act of 2005 (a) Cord blood inventory Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection (h)— (1) in paragraph (1)— (A) by striking $23,000,000 for each of fiscal years 2011 through 2014 and; and (B) by inserting before the period at the end the following: and $23,000,000 for each of fiscal years 2016 through 2020; and (2) in paragraph (2), by striking 2011 through 2015 and inserting 2015 through 2020. (b) National program Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking 2011 through 2014 and inserting 2016 through 2020. September 8, 2015 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed